TESARO Announces Participation at Two Investor Conferences

WALTHAM, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO), an oncology-focused biopharmaceutical company, today announced its participation in two upcoming investor conferences. The two conferences are:     

• The Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida on Wednesday, March 14, 2018. Lonnie Moulder, CEO of TESARO, will participate in an analyst-led moderated Q&A from 2:35 to 3:00 PM ET and in meetings with investors. 
• The Morgan Stanley Healthcare Corporate Access Day at the Boston Harbor Hotel in Boston, Massachusetts on Tuesday, March 20, 2018. Tim Pearson, EVP and CFO of TESARO, will participate in meetings with investors.

A live webcast of the presentation at the Barclays conference will be available by visiting the Investors section of the TESARO website at www.tesarobio.com. Archived replays of these webcasts will be available on the Company’s website for 14 days following the conferences.

About TESAROTESARO is an oncology-focused biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer. For more information, visit www.tesarobio.com, and follow us on Twitter and LinkedIn.

For additional information, please contact:    Jennifer Davis1.781.325.1116[email protected]

You May Also Be Interested In

• bioAffinity Technologies Announces Closing of $4M Private Placement Offering Priced At-the-Market Under Nasdaq Rules
• ETS Launches EvidenceWorks to Power State-Led Education Progress
• Novogradac to Celebrate Affordable Housing Achievements at Upcoming Conference